<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_congeners" title="A Data-Independent Methodology for the Structural Characterization of Microcystins and Anabaenopeptins Leading to the Identification of Four New Congeners" shortTitle="congeners" author="Audrey Roy-Lachapelle, Morgan Solliec, Sébastien Sauvé, Christian Gagnon" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2072-6651/11/11/619/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
1.	LS	1.
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Eutrophication	NN	eutrophication
of	IN	of
natural	JJ	natural
water	NN	water
sources	NNS	source
is	VBZ	be
closely	RB	closely
linked	VBN	link
to	IN	to
the	DT	the
distinctive	JJ	distinctive
appearance	NN	appearance
of	IN	of
massive	JJ	massive
and	CC	and
episodic	JJ	episodic
proliferations	NNS	proliferation
of	IN	of
cyanobacteria	NN	cyanobacteria
.	.	.
</s>
<s type="decl">
These	DT	this
prokaryotic	JJ	prokaryotic
organisms	NNS	organism
do	VBP	do
not	RB	not
systematically	RB	systematically
carry	VB	carry
the	DT	the
expressed	VBN	express
genes	NNS	gene
for	IN	for
toxin	NN	toxin
production	NN	production
,	,	,
yet	CC	yet
about	RB	about
40	CD	40
of	IN	of
the	DT	the
150	CD	150
cyanobacteria	NN	cyanobacteria
genera	NNS	genera
do	VBP	do
possess	VB	possess
these	DT	this
genes	NNS	gene
.	.	.
</s>
<s type="decl">
For	IN	for
more	RBR	more
than	IN	than
two	CD	2
decades	NNS	decade
,	,	,
microcystins	NNS	microcystin
(	-LRB-	(
MCs	NNS	MC
)	-RRB-	)
have	VBP	have
been	VBN	be
the	DT	the
main	JJ	main
family	NN	family
of	IN	of
cyanopeptides	NNS	cyanopeptide
extensively	RB	extensively
studied	VBN	study
.	.	.
</s>
<s type="decl">
This	DT	this
dominance	NN	dominance
has	VBZ	have
been	VBN	be
triggered	VBN	trigger
by	IN	by
tragic	JJ	tragic
incidents	NNS	incident
,	,	,
such	JJ	such
as	IN	as
in	IN	in
a	DT	a
Brazilian	JJ	Brazilian
hospital	NN	hospital
in	IN	in
<date when="1996">
1996	CD	1996
</date>
,	,	,
where	WRB	where
52	CD	52
patients	NNS	patient
undergoing	VBG	undergo
dialysis	NN	dialysis
succumbed	VBD	succumb
to	IN	to
liver	NN	liver
failure	NN	failure
caused	VBN	cause
by	IN	by
contaminated	VBN	contaminate
water	NN	water
with	IN	with
MCs	NNS	MC
.	.	.
</s>
<s type="decl">
Following	VBG	follow
this	DT	this
,	,	,
the	DT	the
World	NNP	World
Health	NNP	Health
Organization	NNP	Organization
(	-LRB-	(
WHO	NNP	WHO
)	-RRB-	)
has	VBZ	have
suggested	VBN	suggest
regulation	NN	regulation
levels	NNS	level
for	IN	for
MC-LR	NNP	MC-LR
in	IN	in
drinking	NN	drinking
water	NN	water
(	-LRB-	(
1	CD	1
µg	NN	hg
L−1	NNP	L−1
)	-RRB-	)
which	WDT	which
was	VBD	be
extended	VBN	extend
by	IN	by
the	DT	the
US	NNP	US
EPA	NNP	EPA
to	IN	to
MC-LR	NNP	MC-LR
equivalents	NNS	equivalent
to	TO	to
include	VB	include
more	JJR	more
congeners	NNS	congener
and	CC	and
other	JJ	other
cyanotoxins	NNS	cyanotoxin
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
several	JJ	several
families	NNS	family
of	IN	of
cyanopeptides	NNS	cyanopeptide
have	VBP	have
long	RB	long
been	VBN	be
identified	VBN	identify
along	RB	along
with	IN	with
MCs	NNS	MC
isolated	VBN	isolate
from	IN	from
common	JJ	common
cyanobacteria	NN	cyanobacteria
,	,	,
i.e.	FW	i.e.
,	,	,
<hi rend="italic">
Microcystis	NNP	Microcystis
</hi>
sp.	NNP	Sp.
Amongst	IN	amongst
them	PRP	they
,	,	,
cyanopeptolins	NNS	cyanopeptolin
,	,	,
anabaenopeptins	NNS	anabaenopeptin
(	-LRB-	(
APs	NNS	ap
)	-RRB-	)
,	,	,
aerucyclamides	NNS	aerucycycide
,	,	,
aeruginosines	NNS	aeruginosine
,	,	,
and	CC	and
microginins	NNS	microginin
are	VBP	be
to	TO	to
mention	VB	mention
when	WRB	when
specifying	VBG	specify
the	DT	the
dominant	JJ	dominant
families	NNS	family
.	.	.
</s>
<s type="decl">
Still	RB	still
,	,	,
the	DT	the
high	JJ	high
diversity	NN	diversity
of	IN	of
produced	VBN	produce
congeners	NNS	congener
from	IN	from
each	DT	each
family	NN	family
and	CC	and
the	DT	the
little	JJ	little
information	NN	information
known	VBN	know
about	IN	about
factors	NNS	factor
and	CC	and
mechanisms	NNS	mechanism
linked	VBN	link
to	IN	to
their	PRP$	their
production	NN	production
greatly	RB	greatly
complicates	VBZ	complicate
their	PRP$	their
study	NN	study
.	.	.
</s>
</p>
<p>
<s type="decl">
Potential	JJ	Potential
cyanopeptides	NNS	cyanopeptide
toxicity	NN	toxicity
critically	RB	critically
depends	VBZ	depend
on	IN	on
the	DT	the
variants	NNS	variant
structure	NN	structure
,	,	,
but	CC	but
is	VBZ	be
still	RB	still
misunderstood	VBN	misunderstand
and	CC	and
poorly	RB	poorly
documented	VBN	document
.	.	.
</s>
<s type="decl">
MCs	NNS	MC
are	VBP	be
hepatotoxic	JJ	hepatotoxic
and	CC	and
readily	RB	readily
accumulated	VBN	accumulate
in	IN	in
the	DT	the
liver	NN	liver
from	IN	from
the	DT	the
specific	JJ	specific
binding	NN	binding
to	IN	to
protein	NN	protein
phosphatases	NNS	phosphatase
1	CD	1
and	CC	and
2A	CD	2A
.	.	.
</s>
<s type="decl">
The	DT	the
latter	NN	latter
causes	VBZ	cause
disruption	NN	disruption
of	IN	of
cellular	JJ	cellular
homeostasis	NN	homeostasis
,	,	,
and	CC	and
,	,	,
in	IN	in
most	JJS	most
acute	JJ	acute
cases	NNS	case
,	,	,
leads	VBZ	lead
to	IN	to
liver	NN	liver
necrosis	NN	necrosis
,	,	,
as	RB	as
well	RB	well
as	IN	as
colorectal	JJ	colorectal
and	CC	and
liver	NN	liver
cancer	NN	cancer
.	.	.
</s>
<s type="decl">
Thus	RB	thus
far	RB	far
,	,	,
bioactive	JJ	bioactive
APs	NNS	ap
are	VBP	be
considered	VBN	consider
non-toxic	JJ	non-toxic
.	.	.
</s>
<s type="decl">
Nevertheless	RB	nevertheless
,	,	,
a	DT	a
few	JJ	few
studies	NNS	study
suggest	VBP	suggest
that	IN	that
some	DT	some
APs	NNS	ap
congeners	NNS	congener
,	,	,
such	JJ	such
as	IN	as
AP-A	NNP	AP-A
,	,	,
may	MD	may
demonstrate	VB	demonstrate
the	DT	the
potential	NN	potential
to	TO	to
inhibit	VB	inhibit
protease	NN	protease
and	CC	and
protein	NN	protein
phosphatases	NNS	phosphatase
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
AP-B	NNP	AP-B
and	CC	and
-F	NN	-F
induce	VBP	induce
cyanobacteria	NN	cyanobacteria
lysis	NN	lysis
,	,	,
ultimately	RB	ultimately
affecting	VBG	affect
the	DT	the
bioavailability	NN	bioavailability
of	IN	of
other	JJ	other
cell-bound	JJ	cell-bound
cyanotoxins	NNS	cyanotoxin
.	.	.
</s>
<s type="decl">
Accordingly	RB	accordingly
,	,	,
much	RB	much
still	RB	still
needs	VBZ	need
to	TO	to
be	VB	be
done	VBN	do
on	IN	on
the	DT	the
unambiguous	JJ	unambiguous
identification	NN	identification
of	IN	of
these	DT	this
cyanopeptides	NNS	cyanopeptide
and	CC	and
the	DT	the
assessment	NN	assessment
of	IN	of
their	PRP$	their
potential	JJ	potential
toxicity	NN	toxicity
.	.	.
</s>
</p>
<p>
<s type="decl">
Cyanopeptide	NNP	Cyanopeptide
’s	POS	's
structures	NNS	structure
are	VBP	be
characterized	VBN	characterize
by	IN	by
cyclic	JJ	cyclic
or	CC	or
linear	JJ	linear
non-ribosomal	JJ	non-ribosomal
peptides	NNS	peptide
,	,	,
each	DT	each
family	NN	family
possessing	VBG	possess
a	DT	a
characteristic	JJ	characteristic
substructure	NN	substructure
and	CC	and
some	DT	some
variable	JJ	variable
amino	NN	amino
acids	NNS	acid
and	CC	and
peptides	NNS	peptide
.	.	.
</s>
<s type="decl">
These	DT	this
variations	NNS	variation
in	IN	in
the	DT	the
core	JJ	core
structure	NN	structure
of	IN	of
each	DT	each
cyanopeptide	NN	cyanopeptide
multiply	VBP	multiply
the	DT	the
number	NN	number
of	IN	of
combinations	NNS	combination
which	WDT	which
is	VBZ	be
the	DT	the
cause	NN	cause
of	IN	of
the	DT	the
large	JJ	large
variety	NN	variety
of	IN	of
potential	JJ	potential
congeners	NNS	congener
;	:	;
to	IN	to
date	NN	date
,	,	,
more	RBR	more
than	IN	than
500	CD	500
cyanopeptides	NNS	cyanopeptide
,	,	,
including	VBG	include
240	CD	240
MCs	NNS	MC
and	CC	and
96	CD	96
APs	NNS	ap
have	VBP	have
been	VBN	be
identified	VBN	identify
.	.	.
</s>
<s type="decl">
More	RBR	more
specifically	RB	specifically
,	,	,
MCs	NNS	MC
are	VBP	be
cyclic	JJ	cyclic
heptapeptides	NNS	heptapeptide
(	:	(
</s>
<figure>
<s type="frag">
Figure	NNP	Figure
1	CD	1
</s>
</figure>
<s type="frag">
)	-RRB-	)
with	IN	with
a	DT	a
characteristic	JJ	characteristic
β-amino	NN	β-amino
acid	NN	acid
moiety	NN	moiety
named	VBN	name
Adda	NNP	Adda
(	-LRB-	(
3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic	NN	3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic
acid	NN	acid
)	-RRB-	)
,	,	,
and	CC	and
two	CD	2
distinctive	JJ	distinctive
positions	NNS	position
with	IN	with
the	DT	the
highest	JJS	high
variation	NN	variation
of	IN	of
monomers	NNS	monomer
(	-LRB-	(
X	NNP	X
and	CC	and
Z	NN	Z
)	-RRB-	)
.	.	.
</s>
<s type="decl">
APs	NNS	ap
are	VBP	be
cyclic	JJ	cyclic
peptides	NNS	peptide
bound	VBN	bind
through	IN	through
a	DT	a
characteristic	JJ	characteristic
ureido-linkage	NN	ureido-linkage
(	:	(
</s>
<figure>
<s type="frag">
Figure	NNP	Figure
1	CD	1
</s>
</figure>
<s type="decl">
)	-RRB-	)
;	:	;
their	PRP$	their
structure	NN	structure
is	VBZ	be
characterized	VBN	characterize
as	IN	as
the	DT	the
following	VBG	follow
:	:	:
AA1-CO-[Lys-AA3-AA4-MeAA5-AA6	NNP	AA1-CO-[Lys-AA3-AA4-MeAA5-AA6
]	-RRB-	]
with	IN	with
AA	NN	AA
representing	VBG	represent
a	DT	a
variable	JJ	variable
amino	NN	amino
acid	NN	acid
residues	NNS	residue
and	CC	and
brackets	NNS	bracket
,	,	,
including	VBG	include
the	DT	the
cyclic	JJ	cyclic
structure	NN	structure
.	.	.
</s>
<s type="sub">
Based	VBN	base
on	IN	on
the	DT	the
various	JJ	various
amino	NN	amino
acid	NN	acid
combinations	NNS	combination
identified	VBN	identify
for	IN	for
these	DT	this
two	CD	2
families	NNS	family
,	,	,
an	DT	a
extensive	JJ	extensive
list	NN	list
of	IN	of
potential	JJ	potential
amino	NN	amino
acids	NNS	acid
per	IN	per
variable	JJ	variable
sites	NNS	site
can	MD	can
be	VB	be
proposed	VBN	propose
to	TO	to
enumerate	VB	enumerate
all	DT	all
possible	JJ	possible
theoretical	JJ	theoretical
combinations	NNS	combination
of	IN	of
cyanopeptides	NNS	cyanopeptide
identifiable	JJ	identifiable
to	IN	to
date	NN	date
.	.	.
</s>
<s type="sub">
Based	VBN	base
on	IN	on
the	DT	the
proposed	VBN	propose
combinations	NNS	combination
,	,	,
one	PRP	one
could	MD	could
theoretically	RB	theoretically
propose	VB	propose
a	DT	a
significantly	RB	significantly
higher	JJR	high
number	NN	number
of	IN	of
congeners	NNS	congener
,	,	,
although	IN	although
most	JJS	most
of	IN	of
the	DT	the
variants	NNS	variant
may	MD	may
not	RB	not
occur	VB	occur
naturally	RB	naturally
in	IN	in
practice	NN	practice
,	,	,
due	JJ	due
to	IN	to
the	DT	the
low	JJ	low
frequency	NN	frequency
of	IN	of
some	DT	some
amino	NN	amino
acids	NNS	acid
in	IN	in
the	DT	the
possible	JJ	possible
combinations	NNS	combination
.	.	.
</s>
</p>
<p>
<s type="decl">
High-resolution	JJ	High-resolution
mass	NN	mass
spectrometry	NN	spectrometry
(	-LRB-	(
HRMS	NNP	HRMS
)	-RRB-	)
can	MD	can
use	VB	use
exact	JJ	exact
mass	NN	mass
measurement	NN	measurement
coupled	VBN	couple
to	IN	to
database	NN	database
and	CC	and
software	NN	software
packages	NNS	package
to	TO	to
become	VB	become
an	DT	a
increasingly	RB	increasingly
more	RBR	more
effective	JJ	effective
tool	NN	tool
regarding	VBG	regard
the	DT	the
accurate	JJ	accurate
identification	NN	identification
of	IN	of
the	DT	the
suspect	NN	suspect
and	CC	and
unknown	JJ	unknown
compounds	NNS	compound
without	IN	without
the	DT	the
use	NN	use
of	IN	of
certified	VBN	certifi
standards	NNS	standard
,	,	,
where	WRB	where
target	NN	target
analysis	NN	analysis
is	VBZ	be
unfeasible	JJ	unfeasible
.	.	.
</s>
<s type="decl">
Suspect	NN	suspect
and	CC	and
non-target	JJ	non-target
screening	NN	screening
are	VBP	be
the	DT	the
two	CD	2
main	JJ	main
strategies	NNS	strategy
used	VBN	use
for	IN	for
the	DT	the
exhaustive	JJ	exhaustive
search	NN	search
of	IN	of
the	DT	the
known	JJ	known
and	CC	and
unknown	JJ	unknown
compound	NN	compound
where	WRB	where
almost	RB	almost
no	DT	no
reference	NN	reference
material	NN	material
is	VBZ	be
available	JJ	available
.	.	.
</s>
<s type="decl">
In	IN	in
recent	JJ	recent
years	NNS	year
,	,	,
the	DT	the
use	NN	use
of	IN	of
these	DT	this
screening	NN	screening
techniques	NNS	technique
in	IN	in
the	DT	the
environmental	JJ	environmental
field	NN	field
has	VBZ	have
greatly	RB	greatly
increased	VBN	increase
,	,	,
particularly	RB	particularly
for	IN	for
the	DT	the
non-target	JJ	non-target
analysis	NN	analysis
of	IN	of
pharmaceuticals	NNS	pharmaceutical
,	,	,
pesticides	NNS	pesticide
,	,	,
hormones	NNS	hormone
in	IN	in
surface	NN	surface
and	CC	and
treated	VBN	treat
water	NN	water
.	.	.
</s>
<s type="decl">
Reversewise	RB	reversewise
,	,	,
the	DT	the
presence	NN	presence
of	IN	of
cyanotoxins	NNS	cyanotoxin
in	IN	in
surface	NN	surface
water	NN	water
has	VBZ	have
only	RB	only
been	VBN	be
investigated	VBN	investigate
by	IN	by
few	JJ	few
authors	NNS	author
using	VBG	use
this	DT	this
type	NN	type
of	IN	of
analysis	NN	analysis
.	.	.
</s>
<s type="decl">
Isobaric	JJ	Isobaric
interferences	NNS	interference
and	CC	and
co-eluting	NN	co-eluting
substances	NNS	substance
can	MD	can
represent	VB	represent
major	JJ	major
challenges	NNS	challenge
in	IN	in
the	DT	the
identification	NN	identification
process	NN	process
of	IN	of
a	DT	a
compound	NN	compound
even	RB	even
when	WRB	when
using	VBG	use
HRMS	NNP	HRMS
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
a	DT	a
sole	JJ	sole
analysis	NN	analysis
,	,	,
based	VBN	base
on	IN	on
the	DT	the
accurate	JJ	accurate
mass	NN	mass
,	,	,
is	VBZ	be
insufficient	JJ	insufficient
to	TO	to
confirm	VB	confirm
a	DT	a
structural	JJ	structural
identification	NN	identification
,	,	,
e.g.	FW	e.g.
,	,	,
determining	VBG	determine
the	DT	the
degradation	NN	degradation
by-products	NNS	by-product
or	CC	or
metabolites	NNS	metabolite
related	VBN	relate
to	IN	to
a	DT	a
compound	NN	compound
of	IN	of
interest	NN	interest
.	.	.
</s>
<s type="sub">
A	DT	a
non-target	JJ	non-target
screening	NN	screening
method	NN	method
should	MD	should
include	VB	include
various	JJ	various
confirmatory	JJ	confirmatory
elements	NNS	element
,	,	,
such	JJ	such
as	IN	as
the	DT	the
accurate	JJ	accurate
mass	NN	mass
(	-LRB-	(
<hi rend="italic">
m/z	NN	mour
</hi>
)	-RRB-	)
,	,	,
mass	NN	mass
defect	NN	defect
,	,	,
isotopic	JJ	isotopic
pattern	NN	pattern
,	,	,
charge	NN	charge
states	NNS	state
,	,	,
adducts	NNS	adduct
and	CC	and
fragmentation	NN	fragmentation
pattern	NN	pattern
that	WDT	that
increase	VBP	increase
the	DT	the
confidence	NN	confidence
of	IN	of
identification	NN	identification
.	.	.
</s>
<s type="decl">
Suspect	NN	suspect
screening	NN	screening
includes	VBZ	include
the	DT	the
benefit	NN	benefit
and	CC	and
disadvantage	NN	disadvantage
to	TO	to
depend	VB	depend
on	IN	on
suspect	NN	suspect
lists	NNS	list
.	.	.
</s>
<s type="decl">
It	PRP	it
is	VBZ	be
mainly	RB	mainly
based	VBN	base
on	IN	on
some	DT	some
of	IN	of
the	DT	the
information	NN	information
mentioned	VBN	mention
above	RB	above
for	IN	for
the	DT	the
identification	NN	identification
,	,	,
but	CC	but
a	DT	a
major	JJ	major
drawback	NN	drawback
comes	VBZ	come
from	IN	from
a	DT	a
lack	NN	lack
of	IN	of
data	NNS	datum
in	IN	in
online	JJ	online
libraries	NNS	library
for	IN	for
some	DT	some
small	JJ	small
molecule	NN	molecule
families	NNS	family
,	,	,
i.e.	FW	i.e.
,	,	,
cyanotoxins	NNS	cyanotoxin
,	,	,
which	WDT	which
allow	VBP	allow
a	DT	a
formal	JJ	formal
identification	NN	identification
.	.	.
</s>
<s type="decl">
Nonetheless	RB	nonetheless
,	,	,
considering	VBG	consider
the	DT	the
possibility	NN	possibility
to	TO	to
build	VB	build
specific	JJ	specific
in-house	NN	in-house
databases	NNS	database
for	IN	for
the	DT	the
unambiguous	JJ	unambiguous
identification	NN	identification
of	IN	of
the	DT	the
known	VBN	know
and	CC	and
unknown	JJ	unknown
cyanopeptides	NNS	cyanopeptide
is	VBZ	be
promising	JJ	promising
for	IN	for
the	DT	the
study	NN	study
and	CC	and
identification	NN	identification
of	IN	of
less	RBR	less
known	VBN	know
congeners	NNS	congener
.	.	.
</s>
</p>
</text>